Wooly Mammoth startup Colossal seeking at least $20B valuation
De-extinction startup Colossal Biosciences is reportedly targeting a valuation between $20 billion and $30 billion in a new funding round.
Velocity timeline
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
Colossal Biosciences, a startup focused on the de-extinction of species such as the wooly mammoth, is in talks to raise new capital. The company is seeking a valuation of at least $20 billion, with some reports indicating it could reach $30 billion.
Coverage from TechCrunch, Axios, and Seeking Alpha emphasizes the scale of the current funding discussions. Reports from Zamin.uz and Межа. Новини України also highlight the potential $30 billion valuation ceiling.
Future developments depend on the outcome of these capital raising talks and the finalization of the company's valuation.
Synthesized by Newsylist from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 6h ago.
Quick answers
What is Colossal Biosciences?
It is a de-extinction startup known for its work regarding the wooly mammoth.
What valuation is the company seeking?
The company is seeking a valuation of at least $20 billion, with reports suggesting a range between $20 billion and $30 billion.
What is the purpose of the current talks?
The company is reportedly in discussions to raise new capital.
Coverage (5)
- Colossal Biosciences seeks 20 to 30 billion valuation in new funding round Межа. Новини України. · 20h ago
- Colossal Biosciences, the de-extinction startup, could reach a $30 billion valuation Zamin.uz · 20h ago
- Colossal Biosciences discussing new funding at $20B or more valuation: report (IBB:NASDAQ) Seeking Alpha · 20h ago
- Colossal Biosciences reportedly in talks to raise new capital at $20B–$30B valuation TechCrunch · 20h ago
- Wooly Mammoth startup Colossal seeking at least $20B valuation Axios · 20h ago broke it first
People, places & organizations
Topics
Related trends
Spotify’s Daniel Ek is bringing his body-scanning clinics to the US
5 news sources are covering this Business story right now — Newsylist is tracking how fast it spreads.
Hermes agent maker Nous Research in talks for new funding at $1.5B valuation
Nous Research is seeking over $75 million in new funding for its open-source Hermes AI agent at a $1.5 billion valuation.
'We're paranoid.' As China biotech competition heats up, American drugmakers get more secretive
6 news sources are covering this Business story right now — Newsylist is tracking how fast it spreads.
AI chip maker SambaNova raises $1B at $11B valuation, 5 months after last mega round
5 news sources are covering this Business story right now — Newsylist is tracking how fast it spreads.
Bezos' Blue Origin valued at $130 billion in first public fundraising round
6 news sources are covering this Business story right now — Newsylist is tracking how fast it spreads.
Blue Origin, for the first time, is expected to raise private capital
6 news sources are covering this Business story right now — Newsylist is tracking how fast it spreads.